Table: begin end state 1 23 cytoplasmic 24 43 transmembrane 44 48 non-cytoplasmic 49 67 transmembrane 68 100 cytoplasmic 101 120 transmembrane 121 139 non-cytoplasmic 140 157 transmembrane 158 164 cytoplasmic 165 185 transmembrane 186 206 non-cytoplasmic 207 233 transmembrane 234 253 cytoplasmic 254 275 transmembrane 276 299 non-cytoplasmic 300 321 transmembrane 322 347 cytoplasmic 348 371 transmembrane 372 375 non-cytoplasmic 376 394 transmembrane 395 405 cytoplasmic 406 428 transmembrane 429 429 non-cytoplasmic
Input: >BWI76_RS22875 METTQTSTIVSDATRSGWRKTDTMWMLGLYGTAIGAGVLFLPINAGVGGMIPLIIMAILA FPMTFFAHRGMTRFVLSGKNPGEDITEVVEEHFGVGAGKLITLLYFFAIYPILLVYSVAI TNTVESFMLHQLHITPPPRAILSLILIVGMMTIVRFGEQMIVKAMSVLVFPFVVALMILA FYLIPQWNGAALETLSLSSATATGNGLWMTLWLAIPVMVFSFNHSPIISSFAVAKREEYG QGAEKKCSSILARAHIMMVLTVMFFVFSCVLSLSPADLAAAKDQNISILSYLANHFNAPV IAWMAPIIAMIAITKSFLGHYLGAREGFNGMVIKSLRGKGKSIEINKLNKITALFMLVTT WIVATLNPSILGMIETLGGPIIAMILFLMPMYAIQKVPAMRKYSGHVSNVFVVIMGLIAI SAIFYSLFS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server